Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Aug 24, 2024 9:08pm
158 Views
Post# 36194938

A.I. is going to vastly improve health care for everyone.🚀

A.I. is going to vastly improve health care for everyone.🚀
1 repost Miro Cernetig 
CEO & Owner of CityAge.com• Join our global network of 25,000+ leaders to connect with technologies and people building the future. We power ideas+brands with bespoke campaigns, content & events. Free membershipCEO & Owner of CityAge.com• Join our global network of 25,000+ leaders to connect with technologies and people building the future. We power ideas+brands with bespoke campaigns, content & events. Free membership
View my newsletter
  2 hours ago
 
 
A.I. is going to vastly improve health care for everyone.
 
One application, now in use, is Ventripoint. It turns ultrasounds of the heart into detailed images that are created in a fraction of the time and cost of using an MRI.
 
It's of real importance in the treatment of infants and children with heart conditions. Caregivers can get inexpensive imagery, in minutes. That's which the Toronto and Seattle Children's hospitals, amongst others, are pioneering its use.
 
This is a great made-in-Canada technology now being used in hospitals in Canada, the U.S., U.K. and Europe. www.ventripoint.com
 
Hugh MacNaught
President and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd.
 hours ago
Yesterday I had the pleasure working with our Clinical Applications Manager Cristina Almeida during her upgrade of the system at the Seattle Children’s Hospital to the new magnet-less sensors. It was a great opportunity to visit a customer site, observe and learn about their clinical environment and workflows, and discuss future development plans. It is clear that the refinements to VMS+ and growing awareness of its capabilities are enabling its use for a growing number of indications and patients.
<< Previous
Bullboard Posts
Next >>